The Kratom industry wants the FDA to send down some regulation

Import alerts, warning letters, and seizures by U.S. Marshals involving the U.S. Food and Drug Administration (FDA) are not uncommon where Kratom is involved.  The tropical tree native to Southeast Asia is not approved for any medical use by the FDA but is often mentioned for one kind of caution or another.

And court action now has the industry crying out for regulation.

A Florida jury on July 31 awarded  $11 million for the wrongful death of a Florida woman.   She died due to “acute mitragynine intoxication.” Mitragynine, one of two main chemical compounds in kratom, produces classic opioid-like effects at high concentrations, such as sedation, nausea, vomiting, addiction, and difficulty breathing, which may be fatal.

Read more at Food Safety News